《腫瘤學(xué)/血液學(xué)評(píng)論》發(fā)表了由世界各地的專家撰寫的關(guān)于腫瘤學(xué)和血液學(xué)所有領(lǐng)域的學(xué)術(shù)評(píng)論。所有自發(fā)邀請(qǐng)或提交的評(píng)審文章在最終驗(yàn)收前都要接受同行評(píng)審?！赌[瘤學(xué)/血液學(xué)評(píng)論》是歐洲腫瘤學(xué)學(xué)院（ESO）的官方期刊。《腫瘤學(xué)/血液學(xué)評(píng)論》的編輯通常不會(huì)考慮提交前的詢問。請(qǐng)參閱腫瘤學(xué)/血液學(xué)的目標(biāo)和范圍中的關(guān)鍵評(píng)論，以確保您的論文符合期刊的范圍。有關(guān)提交手稿和編寫手稿指南的更多信息，請(qǐng)參閱《作者指南》。

Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around the world. All review articles, invited or submitted spontaneously, are subject to peer review before final acceptance. Critical Reviews in Oncology/Hematology is the Official Journal of the European School of Oncology (ESO).The Editors of Critical Reviews in )Oncology/Hematology will usually not consider pre-submission inquiries. Kindly refer to the Critical Reviews in Oncology/Hematology's Aims and Scope to ensure that your paper fits the journal's scope. Further information regarding the submission of manuscripts and guidelines for the preparation of the manuscripts can be found in the Guide for Authors.